Development and evaluation of an enzyme-linked immunosorbent assay to detect Histoplasma capsulatum antigenuria in immunocompromised patients - Wikidata - wikimedia - TriplyDB

Development and evaluation of an enzyme-linked immunosorbent assay to detect Histoplasma capsulatum antigenuria in immunocompromised patients

Development and evaluation of an enzyme-linked immunosorbent assay to detect Histoplasma capsulatum antigenuria in immunocompromised patients

http://www.wikidata.org/entity/Q37213871

about

Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital Validation of an enzyme-linked immunosorbent assay that detects Histoplasma capsulatum antigenuria in Colombian patients with AIDS for diagnosis and follow-up during therapy.Evaluation of an enzyme-linked immunosorbent assay using purified, deglycosylated histoplasmin for different clinical manifestations of histoplasmosis.Urine as a specimen to diagnose infections in twenty-first century: focus on analytical accuracy.Histoplasmosis among hospitalized febrile patients in northern Tanzania Evaluation of commercially available reagents for diagnosis of histoplasmosis infection in immunocompromised patients.Antigen Detection in the Diagnosis of Histoplasmosis: A Meta-analysis of Diagnostic Performance.High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala.Heat Shock Proteins in Histoplasma and Paracoccidioides.Detection of Histoplasma capsulatum DNA in peripheral blood from a patient with ocular histoplasmosis syndrome.Disseminated histoplasmosis and AIDS: a prospective and multicentre study to evaluate the performance of different diagnostic tests.Development of a loop-mediated isothermal amplification method for detection of Histoplasma capsulatum DNA in clinical samples.Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America Histoplasmosis in HIV-Infected Patients: A Review of New Developments and Remaining Gaps.Standardization and validation of real time PCR assays for the diagnosis of histoplasmosis using three molecular targets in an animal model.Disseminated histoplasmosis: case report and review of the literature.Multicenter validation of commercial antigenuria reagents to diagnose progressive disseminated histoplasmosis in people living with HIV/AIDS in two Latin American countries.Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature.

P2860

Q33434294-45CC155C-62F1-4E59-BC48-EEC22C156CE0 Q34260874-F58878C6-CFC6-46BD-80C3-8B3AA8F486B3 Q35052562-09FD14B8-07B6-47D9-AB05-2B1572199C43 Q35928243-BE7B6B3A-DB29-4E96-B07D-6052836D2C8E Q36083873-309BC638-E252-4ABF-9A10-EB52B5E2826C Q37336138-A5539AB1-FCE5-4ED4-B8A3-AD8A5B4C6789 Q38630878-B2E55490-8899-40AA-B2DA-73CAF88ED796 Q38673934-A5C03126-2435-4629-A9C9-47BFDE4323CA Q40048200-F785F860-F070-4A83-B90C-26071016E7F4 Q40319450-EBDC4EC4-4ACC-429F-8E4F-9DF7CE257AF8 Q40604745-EBF0F601-6572-433B-99F9-3FC6D2BF1DED Q41908512-C4F7DC55-A2F5-414C-8EB1-9EAA19597EDA Q42082681-62A9C9E6-FBDD-4586-B99F-C6445CCDEED0 Q42584304-44144112-4E7C-4EB7-AA30-B0406106CF27 Q47245207-A0BF3AF4-6374-4AF0-ABF8-4C7F3CF00874 Q49714482-79AEB0CE-1802-4D14-AA78-15228779A3DA Q54251498-608B3DBF-2C45-40D7-9F68-D22CC269060A Q55709425-76E4010B-4FC5-4653-8600-DDE8F0456158

P2860

Development and evaluation of an enzyme-linked immunosorbent assay to detect Histoplasma capsulatum antigenuria in immunocompromised patients

http://www.wikidata.org/entity/Q37213871

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Development and evaluation of ...... in immunocompromised patients

@en

Development and evaluation of ...... in immunocompromised patients.

@nl

type

label

Development and evaluation of ...... in immunocompromised patients

@en

Development and evaluation of ...... in immunocompromised patients.

@nl

prefLabel

Development and evaluation of ...... in immunocompromised patients

@en

Development and evaluation of ...... in immunocompromised patients.

@nl

P1433

Q37213871-A511F182-EEA5-45B4-8D12-C5D49A88A5D8

P1476

Q37213871-BAE247C2-EBA7-489F-AA17-5930629CCF4C

P2093

Q37213871-2824FD85-FD44-44BC-B4DC-63538C4AC884

Q37213871-3B4DF080-971A-405C-B4A4-1683E118BC58

Q37213871-45CBD820-3284-4FDD-8780-7230365EE3F6

Q37213871-4B966D30-7128-4378-A1ED-21714505F864

Q37213871-4CB4208B-44F3-4C0F-9AA2-54773BED61BD

Q37213871-559697BC-69BA-4C36-A847-37BB73348D6A

Q37213871-584D2D92-4C0F-4917-820C-1454E7C5EE17

Q37213871-7FCD99DC-FD8E-4B1C-99F5-0BA9E310DA8D

Q37213871-8ED795FA-D9D5-4F64-B710-D7FABD480E0F

Q37213871-B2FF744C-1FE6-462D-AD3F-4027B024A292

P2860

Q37213871-167BE77A-5C8E-4C1D-9C38-A31A98A8A341

Q37213871-2795ABCA-FB69-4322-A28A-E17E7E83A18B

Q37213871-282D9D86-58EF-4A6A-8216-8662C5C8E10F

Q37213871-3ABFF595-06DB-443A-ADC9-EE9E345D1F1B

Q37213871-526EACAA-1882-4540-81E8-64934085223C

Q37213871-5843E9F3-B9DE-4A4A-BF3E-A473304F6075

Q37213871-5B393544-A19D-4E51-811E-C8C770F4624F

Q37213871-5EE0E865-0381-49C3-A2DE-05F7280C2101

Q37213871-969B7AE5-E6B3-4C97-81EA-AEEE5AC48105

Q37213871-AFD2E262-DAA2-4763-A97B-ABF649CA5390

P304

Q37213871-FC312A36-0D1A-4CFA-9476-30510D26785C

P31

Q37213871-D3F27192-7D3B-4A37-B959-F45A1E064AC3

P356

Q37213871-7695A129-F7AD-484C-BE39-A33357FC8989

P433

Q37213871-794AE1A5-67DB-43F1-B850-D89CC62E3541

P478

Q37213871-37DE6339-3635-42B6-A8D7-2A5582563C1D

P50

Q37213871-DD63B7E8-C274-4CD6-9EB5-AB0A5B182D85

P577

Q37213871-39A7394E-870D-43FF-B1F8-EED99A1F1DAB

P698

Q37213871-8954E09C-632D-4DEC-AF81-B299D5019268

P932

Q37213871-A7B1D069-BA63-4F39-A2D8-7DA86488E10F

P356

P1433

Clinical and Vaccine Immunology

P1476

Development and evaluation of ...... in immunocompromised patients

@en

P2093

Alejandro Herrera

http://www.w3.org/2001/XMLSchema#string

Blanca E Rivera

http://www.w3.org/2001/XMLSchema#string

Blanca Samayoa

http://www.w3.org/2001/XMLSchema#string

Christina M Scheel

http://www.w3.org/2001/XMLSchema#string

Eduardo Arathoon

http://www.w3.org/2001/XMLSchema#string

Gabriella Raxcaco

http://www.w3.org/2001/XMLSchema#string

John Hart

http://www.w3.org/2001/XMLSchema#string

Lynette Benjamin

http://www.w3.org/2001/XMLSchema#string

Mark D Lindsley

http://www.w3.org/2001/XMLSchema#string

Sandra Lima

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Studies on the growth of Histoplasma capsulatum. III Effect of thiamin and other vitamins on the growth of the yeast and mycelial phases of Histoplasma capsulatum.

Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS.

Production and evaluation of reagents for detection of Histoplasma capsulatum antigenuria by enzyme immunoassay.

Detection of histoplasma antigen by a quantitative enzyme immunoassay

Development of a novel antigen detection test for histoplasmosis.

American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis.

Diagnosis of histoplasmosis in immunosuppressed patients.

Improved salt fractionation of animal serums for immunofluorescence studies.

Immunoenzymatic absorption test for serodiagnosis of paracoccidioidomycosis.

P304

852-858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00066-09

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Beatriz L Gomez

P577

2009-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19357311

http://www.w3.org/2001/XMLSchema#string

P932

2691040

http://www.w3.org/2001/XMLSchema#string